|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
| Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +0.94% | -1.26% | -11.08% | 45.84B | |
| -1.30% | +1.04% | +32.68% | +15.01% | 33.9B | |
| -2.25% | -0.31% | +26.01% | +18.55% | 27.52B | |
| +2.78% | +0.74% | +18.17% | -15.17% | 28.87B | |
| +41.35% | +42.93% | +281.58% | +514.79% | 27.01B | |
| +3.87% | +9.64% | +64.61% | +201.02% | 15.36B | |
| +11.87% | +4.57% | +3,276.98% | +4,354.88% | 15.94B | |
| +1.56% | +1.05% | +68.36% | +157.21% | 14.31B | |
| +1.15% | -2.99% | +36.63% | +3.91% | 13.37B | |
| Average | +6.60% | +6.06% | +422.64% | +582.13% | 24.68B | |
| Weighted average by Cap. | +6.28% | +6.11% | +290.83% | +399.77% |
- Stock Market
- Equities
- Stock
Select your edition
All financial news and data tailored to specific country editions
